Skip to main content

Table 5 Independent predictors of asthma control among asthmatic patients at Northwestern, Ethiopia, bi-variable analysis and multivariate analysis (N = 409)

From: Level of asthma control and its determinants among adults living with asthma attending selected public hospitals in northwestern, Ethiopia: using an ordinal logistic regression model

Variable

COR (95% CI)

P-value

AOR (95% CI)

P-value

Age

0.98 (0.97, 0.99)

0.012

0.99 (0.96, 1.02)

0.52

CCI score

0.86 (0.76, 0.98)

0.034*

0.72(0.51, 0.96)

0.37

Medication burden in number

0.78 (0.65, 0.94)

0.012*

0.80 (0.47, 1.35)

0.41

Belief in medication means score

0.62 (0.44, 0.89)

0.010*

0.59 (0.30, 1.16)

0.13

Lung function test

 FEVs 1, percent predicted

1.10 (1.06,1.14)

< 0.001

1.05 (1.00,1.10)

0.023

 FVC 1, percent predicted

1.12 (1.08,1.07)

< 0.001

1.08 (1.04,1.13)

< 0.001

Gender

 Male

1.59 (1.10, 2.30)

0.013*

6.45(1.28,32.44)

0.024*

 Female

1

 

1

 

Marital status

 Single

3.54 (1.65, 7.61)

0.001*

0.04 (0.01, 1.28)

0.075

 Married

1.82 (1.06,3.09)

0.028*

3.63(1.28,10.28)

0.015*

 Divorced

1.43 (0.54,3.80)

0.46

1.43 (0.23, 9.04)

0.71

 Window

1

 

1

 

Educational level

 Informal education

0.44(0.27, 0.74)

0.002*

1.22 (0.24, 6.24)

0.814

 Low level

0.48 (0.28, 0.80

0.005*

0.86 (0.200, 3.73)

0.814

 High level

1

 

1

 

Occupation

 Government employer

1.46 (0.869, 2.44)

0.153

2.85(0.51, 16.02)

0.23

 Private employer

0.81 (0.44, 1.41)

0.506

0.28(0.04, 1.91)

0.20

 Homemaker

0.50 (0.29, 0.87)

0.014*

0.39 (0.09, 1.62)

0.19

 Farmer

1

 

1

 

Biomass use

No

1.82(1.01, 3.21)

0.048*

6.04(1.59,22.87)

0.008*

yes

1

 

1

 

Year of onset

 <  12 years

1.81 (1.19, 2.77)

0.006*

1.78 (0.96,4.77)

0.22

 ≥ 12 year

1

 

1

 

Exacerbation -Menstruation

 Yes

2.05 (1.02, 4.12)

0.045

1.55 (0.55, 4.32)

0.405

 No

1

 

1

 

Relationship with HCP

 Poor

0.06 (0.02, 0.18)

0.000**

0.024(0.02, 0.23)

0.001*

 Good

1

 

1

 

Information by HCP

 No

0.48 (0.31, 0.73)

0.001*

1.28 (0.45, 3.60)

0.64

 Yes

1

 

1

 

Patient role of enablement

 Low

0.24 (0.16, 0.36)

0.000**

0.19 (0.08, 0.49)

0.001*

 High

1

 

1

 

Asthma severity

 Intermittent

1.22 (0.51, 2.95)

0.65

2.7 (0.21,35.2)

0.443

 Mild persistent

1.57 (0.84, 2.91)

0.158

2.45 (0.27,22.1)

0.424

 Moderate persistent

1.35 (0.76, 2.40)

0.299

2.2 (0.31,16.2)

0.429

 Sever persistent R

1

 

1

 

Asthma medication

ICS + SABA

2.45 (0.571,10.56)

0.21

1.19(0.09,16.2)

0.89

Oral +SABA

2.8 (0.55,14.23)

0.20

4.2 (0.18,95)

0.37

ICS + SABA+oral

1.9 (0.42,9.02)

0.39

6.3 (0.91,45)

0.95

Nonsteroid+SABA

1

 

1

 

Concurrent medication Class

 CVD

0.79 (0.04,16.07)

0.884

2.3(0.42,12.5)

0.68

 Endocrine drug

0.41(0.02, 8.30)

0.558

2.5 (0.47,13.7)

0.65

 GI Drug

0.07 (0.002, 2.87)

0.164

0.17(0.00, 1,24)

0.49

 Antipain

1.05 (0.05, 20.63

0.977

1.1 (0.45,26)

0.952

 ART drugs

1

 

1

 

Appropriateness of dose

 Optimal

3.10 (2.04, 4.71)

0.000**

2.16 (0.86, 5.44)

0.101

 Sub-optimal

1

 

1

 

HCP adherence to our guidelines

 Yes

4.87 (3.00, 7.89)

0.001

8.4(2.70, 26.01)

0.001**

 No

1

 

1

 

Appropriateness base on severity

 Yes

4.19 (2.75, 6.38)

0.00**

2.02 (0.72, 5.70)

0.18

 No

1

 

1

 

Comorbidity

 Yes

0.60 (0.42, 0.88)

0.008*

1.677 (0.487, 5.771)

0.41

 No

1

 

1

 

Adherence

 Low

0.304 (0.17, 0.52)

0.00**

0.16 (0.059, 0.481)

0.001**

 High

1

 

1

 
  1. * p < 0.05,** p < 0.001, ominous test,p < 0.001, VIF < 5, likelihood ratio = 158.445, log likelihood = − 126.091,ICS Inhaled corticosteroid, CVD Cardiovascular drug, GI Gasero intestinal, HCP Healthcare provider, SABA Salbutamol, ART Antiretroviral therapy